Bausch & Lomb UK limited has informed the MHRA of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.
How do I know if I have a faulty pen?
All Emerade pens currently on the market have a low risk of being defective but there is no way for the patient to tell by looking at an unused device that it is faulty.
Before use, you can see the solution as clear and colourless in the inspection window of the pen by lifting the label. If you need to use a pen and it works properly, you will see the plunger rod visible in the whole of the inspection window. If it fails to activate properly, you may not see the plunger rod appear in the viewing window as you would do normally. Please note however that you may still hear an audible click even it has not worked correctly. If you stlll feel unwell after your first injection you should administer your second pen without delay. You should make sure you carry two devices at all times.
Pens are currently being manufactured with full corrective actions. The company has advised that Emerade manufactured with all the corrective processes will be introduced into the market from mid-July 2019. For enquiries regarding stock, please contact Bausch & Lomb Customer Services, Tel: 0208 781 2991 Email: [email protected]